Sandbox Reserved 966: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
{| | {| | ||
| [[Image:ramachandran3BON.png| | | [[Image:ramachandran3BON.png|thumb|'''Figure 1 :''' Ramachandran diagram of C.botulinum neurotoxin serotype A light chain (made using Python by Rémi Pelletier)]] | ||
| | | | ||
|} | |} | ||
The <scene name='60/604485/Secondary_structure/1'>Secondary structure</scene> of BoNT/A-LC<ref>http://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=3BON&bionumber=1</ref> | The <scene name='60/604485/Secondary_structure/1'>Secondary structure</scene> of BoNT/A-LC<ref>http://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=3BON&bionumber=1</ref> | ||
| Line 36: | Line 36: | ||
=== Structural highlights === | === Structural highlights === | ||
== Mechanism == | == Mechanism == | ||
[[Image:Mecanismefinal.jpg|left|200px]] | |||
== Therapeutic applications == | == Therapeutic applications == | ||
In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process. | In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process. | ||
